EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

CytoDyn Provides Update on Phase 2 Clinical Trial with PRO 140 in GvHD

Patient enrollment proceeding under amended protocol CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company developing new antibody therapies for combating human immuno...
20 June 2018 Europe clinical | CytoDyn
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte